Tremella and Increased Gray Matter Volume

Doses used in studies

Time to effect

Median: 8 weeks · IQR 8 weeks–8 weeks · Range 8 weeks–8 weeks — Reported in 1 of 1 study

Safety in these studies

Overall tolerabilityNo significant differencehigh-dose TF (40.4%), low-dose TF (35.1%), and placebo (41.4%)
Overall frequency of adverse events did not differ among high-dose TF (40.4%), low-dose TF (35.1%), and placebo groups (41.4%).
from: Efficacy and Safety of Tremella fuciformis in Individuals with Subjective Cognitive Impair
Overall tolerabilityReported
Overall frequency of adverse events did not differ among high-dose TF (40.4%), low-dose TF (35.1%), and placebo groups (41.4%).
from: Efficacy and Safety of Tremella fuciformis in Individuals with Subjective Cognitive Impair

1 of 1 paper

Efficacy and Safety of Tremella fuciformis in Individuals with Subjective Cognitive Impairment: A Randomized Controlled Trial.